SCHOTT Pharma
Bertram Kimmerle, PhD has a diverse work experience spanning various industries and positions. Bertram started their career as a Teaching Assistant at Arizona State University in 2003. Bertram then worked as a Researcher at the Karlsruhe Institute of Technology (KIT) and the University of Karlsruhe (TH) from 2004 to 2006. From 2006 to 2010, they were a Doctoral Researcher at ETH Zurich. Following their doctoral studies, they worked as a Postdoctoral Researcher at ICIQ from 2010 to 2011.
In 2011, they joined Lonza as a Project Manager for Investment Projects, where they were responsible for designing, constructing, and starting up chemical and pharmaceutical production plants. Bertram worked on project coordination between different departments within the company until 2013.
In 2013, Kimmerle joined SCHOTT, initially as a Project Manager for Product Development, overseeing the development of pharmaceutical primary packaging and combination products. Bertram then held various roles, including Head of Product Engineering Sterile & Bulk, Deputy Director of Product Development, and Director of Product Development. From May 2022 to August 2022, they served as Vice President of Research & Development at SCHOTT. In August 2022, they were promoted to Vice President of R&D and Global Engineering, a position they still hold.
Kimmerle's current role at SCHOTT Pharma is as the Vice President of R&D and Global Engineering, where they lead research and development initiatives and oversees engineering operations on a global scale.
Bertram Kimmerle, PhD, completed a Bachelor's degree in Economics from FernUniversität in Hagen from 2008 to 2013. Bertram then pursued a Doctor of Science degree in Chemical Engineering from ETH Zürich from 2006 to 2010. Prior to that, they obtained a Dipl.-Ing. degree in Chemical Engineering / Process Engineering from Karlsruhe Institute of Technology (KIT) from 2000 to 2005. In 2020 to 2021, they attended Malik Academy to study Management, although the degree name is not specified. Additionally, it is mentioned that Bertram Kimmerle has studied Photochemistry and Spectroscopy, but the specific duration or degree obtained from Arizona State University is not provided.
This person is not in any offices
SCHOTT Pharma
1 followers
SCHOTT Pharma designs solutions grounded in science to ensure that medications are safe and easy to use for people around the world – because human health matters. Every day, more than 4,700 people from 65 nations work at SCHOTT Pharma to contribute to global healthcare. The company has 17 manufacturing sites across major pharmaceutical hubs in Europe, the Americas and Asia. SCHOTT Pharma maintains a diverse portfolio of injectable drug containment and delivery solutions. These solutions range from prefillable glass and polymer syringes, cartridges, vials and ampoules. The company has focused on developing innovations for future technologies by: • Creating over 1000 patents and technologies developed in-house • Building a state-of-the-art Research and Development Center in Switzerland • Absorbing over 130 professionals focused on Research and Development Despite being a pharmaceutical manufacturer, SCHOTT Pharma aims to become climate-neutral by 2030. The company commits to this through sustainable development approaches in the society and the environment. Based in Mainz, Germany, it is part of SCHOTT AG that falls under the Carl Zeiss Foundation. SCHOTT Pharma has over 1700 global customers, 30 of which are the leading pharmaceutical manufacturers of injectable drugs. These customers have generated combined sales of EUR 899 million in the fiscal year 2023. Contact us now: pharma@schott.com Data protection: https://www.schott-pharma.com/en/legal-social